Cruz JV - Search Results

1

An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists.

Ferreira EFB, Silva LB, Cruz JV, Araújo PHF, Kimani NM, Leite FHA, Campos JM, Santos CBR. Ferreira EFB, et al. Among authors: cruz jv. Curr Med Chem. 2021;28(29):5884-5895. doi: 10.2174/0929867328666210217153609. Curr Med Chem. 2021. PMID: 33596793 Review.

2

Virtual Screening and Statistical Analysis in the Design of New Caffeine Analogues Molecules with Potential Epithelial Anticancer Activity.

da Silva Costa J, da Silva Lopes Costa K, Cruz JV, da Silva Ramos R, Silva LB, Do Socorro Barros Brasil D, de Paula da Silva CHT, Dos Santos CBR, da Cruz Macedo WJ. da Silva Costa J, et al. Among authors: cruz jv. Curr Pharm Des. 2018;24(5):576-594. doi: 10.2174/1381612823666170711112510. Curr Pharm Des. 2018. PMID: 28699538 Free PMC article.

3

Identification of Novel Protein Kinase Receptor Type 2 Inhibitors Using Pharmacophore and Structure-Based Virtual Screening.

Cruz JV, Neto MFA, Silva LB, da S Ramos R, da S Costa J, Brasil DSB, Lobato CC, da Costa GV, Bittencourt JAHM, da Silva CHTP, Leite FHA, Santos CBR. Cruz JV, et al. Molecules. 2018 Feb 18;23(2):453. doi: 10.3390/molecules23020453. Molecules. 2018. PMID: 29463017 Free PMC article.

4

Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics.

Cruz JV, Serafim RB, da Silva GM, Giuliatti S, Rosa JMC, Araújo Neto MF, Leite FHA, Taft CA, da Silva CHTP, Santos CBR. Cruz JV, et al. J Mol Model. 2018 Aug 7;24(9):225. doi: 10.1007/s00894-018-3756-y. J Mol Model. 2018. PMID: 30088101

5

Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach.

Leão RP, Cruz JV, da Costa GV, Cruz JN, Ferreira EFB, Silva RC, de Lima LR, Borges RS, Dos Santos GB, Santos CBR. Leão RP, et al. Among authors: cruz jv, cruz jn. Pharmaceuticals (Basel). 2020 Aug 26;13(9):209. doi: 10.3390/ph13090209. Pharmaceuticals (Basel). 2020. PMID: 32858871 Free PMC article.

6

Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches.

Cruz JV, Giuliatti S, Alves LB, Silva RC, Ferreira EFB, Kimani NM, Silva CHTP, Souza JSN, Espejo-Román JM, Santos CBR. Cruz JV, et al. J Biomol Struct Dyn. 2022 Aug;40(12):5386-5408. doi: 10.1080/07391102.2020.1871413. Epub 2021 Jan 10. J Biomol Struct Dyn. 2022. PMID: 33427075

7

The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review.

Cruz JV, Rosa JMC, Kimani NM, Giuliatti S, Dos Santos CBR. Cruz JV, et al. Curr Med Chem. 2022;29(17):3028-3049. doi: 10.2174/0929867328666210910125229. Curr Med Chem. 2022. PMID: 34514981 Review.

8

Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach.

Silva LB, Ferreira EFB, Maryam, Espejo-Román JM, Costa GV, Cruz JV, Kimani NM, Costa JS, Bittencourt JAHM, Cruz JN, Campos JM, Santos CBR. Silva LB, et al. Among authors: cruz jv. Molecules. 2023 Jan 19;28(3):1035. doi: 10.3390/molecules28031035. Molecules. 2023. PMID: 36770702 Free PMC article.

9

MTOR gene variants are associated with severe COVID-19 outcomes: A multicenter study.

Tosta BR, de Almeida IM, da Cruz Pena L, Dos Santos Silva H, Reis-Goes FS, Silva NN, Cruz JVA, Dos Anjos Silva M, de Araújo JF, Rodrigues JL, Oliveira G, Figueiredo RG, Vaz SN, Montaño-Castellón I, Santana D, de Lima Beltrão FE, Carneiro VL, Campos GS, Brites C, Fortuna V, Figueiredo CA, Trindade SC, Ramos HE, Costa RDS. Tosta BR, et al. Among authors: cruz jva. Int Immunopharmacol. 2023 Dec;125(Pt B):111155. doi: 10.1016/j.intimp.2023.111155. Epub 2023 Nov 9. Int Immunopharmacol. 2023. PMID: 37951192

10

Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease.

Jones KM, Mangin EN, Reynolds CL, Villanueva LE, Cruz JV, Versteeg L, Keegan B, Kendricks A, Pollet J, Gusovsky F, Bottazzi ME, Hotez PJ. Jones KM, et al. Among authors: cruz jv. Front Cell Infect Microbiol. 2023 Feb 9;13:1106315. doi: 10.3389/fcimb.2023.1106315. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36844399 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page